» Articles » PMID: 34178043

Assembling Disease Networks From Causal Interaction Resources

Overview
Journal Front Genet
Date 2021 Jun 28
PMID 34178043
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

The development of high-throughput high-content technologies and the increased ease in their application in clinical settings has raised the expectation of an important impact of these technologies on diagnosis and personalized therapy. Patient genomic and expression profiles yield lists of genes that are mutated or whose expression is modulated in specific disease conditions. The challenge remains of extracting from these lists functional information that may help to shed light on the mechanisms that are perturbed in the disease, thus setting a rational framework that may help clinical decisions. Network approaches are playing an increasing role in the organization and interpretation of patients' data. Biological networks are generated by connecting genes or gene products according to experimental evidence that demonstrates their interactions. Till recently most approaches have relied on networks based on physical interactions between proteins. Such networks miss an important piece of information as they lack details on the functional consequences of the interactions. Over the past few years, a number of resources have started collecting causal information of the type protein A activates/inactivates protein B, in a structured format. This information may be represented as signed directed graphs where physiological and pathological signaling can be conveniently inspected. In this review we will (i) present and compare these resources and discuss the different scope in comparison with pathway resources; (ii) compare resources that explicitly capture causality in terms of data content and proteome coverage (iii) review how causal-graphs can be used to extract disease-specific Boolean networks.

Citing Articles

Curation of causal interactions mediated by genes associated with autism accelerates the understanding of gene-phenotype relationships underlying neurodevelopmental disorders.

Iannuccelli M, Vitriolo A, Licata L, Lo Surdo P, Contino S, Cheroni C Mol Psychiatry. 2023; 29(1):186-196.

PMID: 38102483 PMC: 11078740. DOI: 10.1038/s41380-023-02317-3.


A Resource to Infer Molecular Paths Linking Cancer Mutations to Perturbation of Cell Metabolism.

Iannuccelli M, Lo Surdo P, Licata L, Castagnoli L, Cesareni G, Perfetto L Front Mol Biosci. 2022; 9:893256.

PMID: 35664677 PMC: 9158333. DOI: 10.3389/fmolb.2022.893256.

References
1.
Zhang P, Itan Y . Biological Network Approaches and Applications in Rare Disease Studies. Genes (Basel). 2019; 10(10). PMC: 6827097. DOI: 10.3390/genes10100797. View

2.
Perfetto L, Briganti L, Calderone A, Cerquone Perpetuini A, Iannuccelli M, Langone F . SIGNOR: a database of causal relationships between biological entities. Nucleic Acids Res. 2015; 44(D1):D548-54. PMC: 4702784. DOI: 10.1093/nar/gkv1048. View

3.
Flobak A, Baudot A, Remy E, Thommesen L, Thieffry D, Kuiper M . Discovery of Drug Synergies in Gastric Cancer Cells Predicted by Logical Modeling. PLoS Comput Biol. 2015; 11(8):e1004426. PMC: 4567168. DOI: 10.1371/journal.pcbi.1004426. View

4.
Licata L, Lo Surdo P, Iannuccelli M, Palma A, Micarelli E, Perfetto L . SIGNOR 2.0, the SIGnaling Network Open Resource 2.0: 2019 update. Nucleic Acids Res. 2019; 48(D1):D504-D510. PMC: 7145695. DOI: 10.1093/nar/gkz949. View

5.
Subramanian A, Tamayo P, Mootha V, Mukherjee S, Ebert B, Gillette M . Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A. 2005; 102(43):15545-50. PMC: 1239896. DOI: 10.1073/pnas.0506580102. View